Femasys Inc. (FEMY)
FEMY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.76
+0.57% on the day
Market cap
$14.7M
Nano cap
Revenue · 2025
$2.3M
+40.8% on 2024
Net income · 2025
-$18.6M
-812.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | FEMY on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001339005 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.3M |
| Net income | -$18.6M |
| Operating income | -$17.6M |
| Net margin | -812.3% |
| Operating margin | -767.0% |
| Revenue growth | +40.8% |
| Cash | $9.3M |
| Total assets | $20.7M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 6.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-29 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-08-14 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 339 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SINT | SiNtx Technologies Inc. | $2.07 | -2.82% | $15.6M |
| CNSY | Cerenome Inc. Common Stock | $1.74 | -3.87% | $13.2M |
| PLSM | Pulsenmore Ltd. | $1.90 | +4.40% | $12.4M |
| RVP | Retractable Technologies Inc. | $0.6100 | -6.15% | $18.3M |
| ICU | SeaStar Medical Holding Corporation | $3.59 | -6.75% | $18.9M |
| CTSO | Cytosorbents Corporation | $3.46 | -3.62% | $10.9M |
| MODD | Modular Medical Inc. | $2.14 | -20.15% | $20.3M |
| PAVM | PAVmed Inc. | $2.64 | -1.86% | $21.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier